Most significantly, its patent in China is set to expire in 2026, which means that the entry of generics could make China the largest market for semaglutide medications
It is also used for heart disease, premenstrual syndrome (PMS), depression, morning sickness, Alzheimer disease, menstrual cramps, diabetes, and many other conditions, but there is no good scientific evidence to support many of these other uses
Diabetes Care 28(5):10681076
Any references to SoundCloud or Spotify are made solely to identify the platforms relevant to the services offered
Duhalde-Vega, M
doi:10.1016/j.diabet.2023.101470 Press Release on Oral Semaglutide Phase 3 Topline Data: "The EVOKE and EVOKE+ clinical trials did not demonstrate a statistically significant reduction in Alzheimer's disease progression."